Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated deficit/Retained Earnings
Beginning balance at Dec. 31, 2020	$ 323,197	$ 35	$ 396,443	$ 617	$ (73,898)
Beginning balance (in shares) at Dec. 31, 2020		35,044,758
Stock-based compensation	2,584		2,584
Common stock issued upon exercises of options	667		667
Common stock issued upon exercises of options (in shares)		56,241
Currency translation adjustment	(305)			(305)
Net income (loss)	(13,534)				(13,534)
Ending balance at Mar. 31, 2021	312,609	$ 35	399,694	312	(87,432)
Ending balance (in shares) at Mar. 31, 2021		35,100,999
Beginning balance at Dec. 31, 2020	323,197	$ 35	396,443	617	(73,898)
Beginning balance (in shares) at Dec. 31, 2020		35,044,758
Net income (loss)	(39,993)
Ending balance at Jun. 30, 2021	289,498	$ 35	403,116	238	(113,891)
Ending balance (in shares) at Jun. 30, 2021		35,148,110
Beginning balance at Dec. 31, 2020	323,197	$ 35	396,443	617	(73,898)
Beginning balance (in shares) at Dec. 31, 2020		35,044,758
Net income (loss)	214,500
Ending balance at Dec. 31, 2021	552,820	$ 35	413,180	(1,018)	140,623
Ending balance (in shares) at Dec. 31, 2021		35,466,001
Beginning balance at Mar. 31, 2021	312,609	$ 35	399,694	312	(87,432)
Beginning balance (in shares) at Mar. 31, 2021		35,100,999
Stock-based compensation	3,227		3,227
Common stock issued upon exercises of options	195		195
Common stock issued upon exercises of options (in shares)		47,111
Currency translation adjustment	(74)			(74)
Net income (loss)	(26,459)				(26,459)
Ending balance at Jun. 30, 2021	289,498	$ 35	403,116	238	(113,891)
Ending balance (in shares) at Jun. 30, 2021		35,148,110
Beginning balance at Dec. 31, 2021	552,820	$ 35	413,180	(1,018)	140,623
Beginning balance (in shares) at Dec. 31, 2021		35,466,001
Stock-based compensation	4,193	$ 0	4,193
Common stock issued upon exercises of options	333	$ 1	332
Common stock issued upon exercises of options (in shares)		50,911
Currency translation adjustment	(550)	$ 0		(550)
Net income (loss)	69,582	0			69,582
Ending balance at Mar. 31, 2022	626,378	$ 36	417,705	(1,568)	210,205
Ending balance (in shares) at Mar. 31, 2022		35,516,912
Beginning balance at Dec. 31, 2021	$ 552,820	$ 35	413,180	(1,018)	140,623
Beginning balance (in shares) at Dec. 31, 2021		35,466,001
Common stock issued upon exercises of options (in shares)	109,322
Net income (loss)	$ 75,208
Ending balance at Jun. 30, 2022	637,301	$ 36	423,743	(2,309)	215,831
Ending balance (in shares) at Jun. 30, 2022		35,575,323
Beginning balance at Mar. 31, 2022	626,378	$ 36	417,705	(1,568)	210,205
Beginning balance (in shares) at Mar. 31, 2022		35,516,912
Stock-based compensation	5,760		5,760
Common stock issued upon exercises of options	278		278
Common stock issued upon exercises of options (in shares)		58,411
Currency translation adjustment	(741)			(741)
Net income (loss)	5,626				5,626
Ending balance at Jun. 30, 2022	$ 637,301	$ 36	$ 423,743	$ (2,309)	$ 215,831
Ending balance (in shares) at Jun. 30, 2022		35,575,323